tradingkey.logo

tradingkey.logo
怜玢


Turn Therapeutics Ord Shs

TTRX
りォッチリストに远加
9.345USD
-0.785-7.75%
終倀 11-13 16:00ET
285.30M時䟡総額
損倱額盎近12ヶ月PER

Turn Therapeutics Ord Shsに぀いお 䌁業名

Turn Therapeutics Inc. is a pharmaceutical and medical device development company built around a proprietary platform of technology designed to enhance drug performance. Its patented mixing process-commercially referred to as PermaFusion-enables stable suspension of polar, water-soluble active pharmaceutical ingredients (APIs) in oil-based carriers without the use of emulsifiers. Its primary development programs focus on dermatological diseases, including moderate to severe eczema and onychomycosis. Its products and programs include GX-03/Hexagen for Wounds (Hexagen (K160872)), GX-03/Hexagen for Derm (AtopX (K171191)), Sterile Gauze Impregnated with GX-03/Hexagen (XEAL (K183681)), Sterile Collagen/Hexagen Powder (FleX Product), GX-03/Hexagen for Moderate-Severe Eczema, and GX-03/Hexagen for Onychomycosis. GX-03/Hexagen for Wounds (Hexagen (K160872)) is a medical device for treating wounds and burns. GX-03/Hexagen for Derm (AtopX (K171191)) is a medical device for managing dermatitis.

Turn Therapeutics Ord Shs プロフィヌル


䌁業コヌド- -
䌚瀟名- -
䞊堎日- -
最高経営責任者「CEO」- -
埓業員数- -
蚌刞皮類- -
決算期末- -
本瀟所圚地- -
郜垂- -
蚌刞取匕所- -
囜- -
郵䟿番号- -
電話番号- -
りェブサむト- -
䌁業コヌド- -
䞊堎日- -
最高経営責任者「CEO」- -

Turn Therapeutics Ord Shsの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Arthur F. Golden
Mr. Arthur F. Golden
Independent Director
Independent Director
970.60K
+62.85%
Mr. Martin Dewhurst
Mr. Martin Dewhurst
Independent Director
Independent Director
21.88K
--
Mr. Zuraiz Chaudhary
Mr. Zuraiz Chaudhary
Interim Chief Financial Officer, Chief Accounting Officer, Vice President - Finance
Interim Chief Financial Officer, Chief Accounting Officer, Vice President - Finance
12.50K
--
Mr. Andrew Gengos
Mr. Andrew Gengos
Independent Director
Independent Director
10.00K
--
Dr. Neilesh Shailesh (Neil) Ghodadra
Dr. Neilesh Shailesh (Neil) Ghodadra
Chief Medical Officer, Director
Chief Medical Officer, Director
10.00K
--
Dr. Kent Kester
Dr. Kent Kester
Independent Director
Independent Director
10.00K
--
Mr. Bradley Burnam
Mr. Bradley Burnam
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Col. (Retd.) Dr. Robert R. Redfield, M.D.
Col. (Retd.) Dr. Robert R. Redfield, M.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Arthur F. Golden
Mr. Arthur F. Golden
Independent Director
Independent Director
970.60K
+62.85%
Mr. Martin Dewhurst
Mr. Martin Dewhurst
Independent Director
Independent Director
21.88K
--
Mr. Zuraiz Chaudhary
Mr. Zuraiz Chaudhary
Interim Chief Financial Officer, Chief Accounting Officer, Vice President - Finance
Interim Chief Financial Officer, Chief Accounting Officer, Vice President - Finance
12.50K
--
Mr. Andrew Gengos
Mr. Andrew Gengos
Independent Director
Independent Director
10.00K
--
Dr. Neilesh Shailesh (Neil) Ghodadra
Dr. Neilesh Shailesh (Neil) Ghodadra
Chief Medical Officer, Director
Chief Medical Officer, Director
10.00K
--
Dr. Kent Kester
Dr. Kent Kester
Independent Director
Independent Director
10.00K
--

よくある質問

Turn Therapeutics Ord Shsの䞊䜍5名の株䞻は誰ですか


Turn Therapeutics Ord Shsの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Arthur F. Golden
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。